SWI/SNF-compromised cancers are susceptible to bromodomain inhibitors

T Shorstova, M Marques, J Su, J Johnston… - Cancer research, 2019 - AACR
The antitumor activity of bromodomain and extraterminal motif protein inhibitors (BETi) has
been demonstrated across numerous types of cancer. As such, these inhibitors are currently …

Somatic BRCA1/2 Recovery as a Resistance Mechanism After Exceptional Response to Poly (ADP-ribose) Polymerase Inhibition

S Lheureux, JP Bruce, JV Burnier… - Journal of clinical …, 2017 - ascopubs.org
Purpose Durable and long-term responses to the poly (ADP-ribose) polymerase inhibitor
olaparib are observed in patients without BRCA1/2 mutations. However, beyond BRCA1/2 …

CTCF facilitates DNA double-strand break repair by enhancing homologous recombination repair

K Hilmi, M Jangal, M Marques, T Zhao, A Saad… - Science …, 2017 - science.org
The repair of DNA double-strand breaks (DSBs) is mediated via two major pathways,
nonhomologous end joining (NHEJ) and homologous recombination (HR) repair. DSB …

[HTML][HTML] Non-alcoholic fatty liver disease in mice with heterozygous mutation in TMED2

W Hou, S Gupta, MC Beauchamp, L Yuan… - PLoS …, 2017 - journals.plos.org
The t rans m embrane e mp24 d omain/p24 (TMED) family are essential components of the
vesicular transport machinery. Members of the TMED family serve as cargo receptors …

[HTML][HTML] Oncogenic activity of poly (ADP-ribose) glycohydrolase

M Marques, M Jangal, LC Wang, A Kazanets… - Oncogene, 2019 - nature.com
Abstract Poly (ADP-ribosylation), known as PARylation, is a post-translational modification
catalyzed by poly (ADP-ribose) polymerases (PARP) and primarily removed by the enzyme …

[HTML][HTML] RBR-type E3 ubiquitin ligase RNF144A targets PARP1 for ubiquitin-dependent degradation and regulates PARP inhibitor sensitivity in breast cancer cells

Y Zhang, XH Liao, HY Xie, ZM Shao, DQ Li - Oncotarget, 2017 - ncbi.nlm.nih.gov
Abstract Poly (ADP-ribose) polymerase 1 (PARP1), a critical DNA repair protein, is
frequently upregulated in breast tumors with a key role in breast cancer progression …

[HTML][HTML] The prognostic value of PARP expression in high-grade epithelial ovarian cancer

S Molnár, L Beke, G Méhes, R Póka - Pathology & Oncology Research, 2020 - Springer
In an attempt to clarify the prognostic relevance of poly (ADP-ribose) polymerase (PARP)
expression, we analysed the clinical data of 86 high-grade epithelial ovarian cancer (EOC) …

[HTML][HTML] Inhibition of poly ADP-ribose glycohydrolase sensitizes ovarian cancer cells to poly ADP-ribose polymerase inhibitors and platinum agents

E Matanes, VM Lopez-Ozuna, D Octeau… - Frontiers in …, 2021 - frontiersin.org
Background Poly ADP-ribose glycohydrolase (PARG) is responsible for the catabolism of
PARP-synthesized PAR to free ADP-ribose. Inhibition of PARG leads to DNA repair …

Assessment of PARP protein expression in epithelial ovarian cancer by ELISA pharmacodynamic assay and immunohistochemistry

K Veskimäe, S Staff, A Grönholm, M Pesu… - Tumor Biology, 2016 - Springer
Targeting Poly (ADP-ribose) polymerase 1 (PARP-1) involved in base excision repair (BER)
has been shown to be a clinically effective treatment strategy in epithelial ovarian cancer …

Reprogramming of nucleotide metabolism mediates synergy between epigenetic therapy and MAP kinase inhibition

T Shorstova, J Su, T Zhao, M Dahabieh… - Molecular Cancer …, 2021 - AACR
Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT) is a rare but often lethal
cancer that is diagnosed at a median age of 24 years. Optimal management of patients is …